Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5281849
Max Phase: Preclinical
Molecular Formula: C30H36N7O8P
Molecular Weight: 653.63
Associated Items:
ID: ALA5281849
Max Phase: Preclinical
Molecular Formula: C30H36N7O8P
Molecular Weight: 653.63
Associated Items:
Canonical SMILES: C[C@H](NP(=O)(N[C@@H](C)C(=O)OCc1ccccc1)OC[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)O1)C(=O)OCc1ccccc1
Standard InChI: InChI=1S/C30H36N7O8P/c1-19(29(39)42-14-21-9-5-3-6-10-21)35-46(41,36-20(2)30(40)43-15-22-11-7-4-8-12-22)44-16-23-13-24(38)28(45-23)37-18-34-25-26(31)32-17-33-27(25)37/h3-12,17-20,23-24,28,38H,13-16H2,1-2H3,(H2,31,32,33)(H2,35,36,41)/t19-,20-,23-,24+,28+/m0/s1
Standard InChI Key: XUUDYJGCIGPNJB-ZEKBRLKRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 653.63 | Molecular Weight (Monoisotopic): 653.2363 | AlogP: 2.62 | #Rotatable Bonds: 14 |
Polar Surface Area: 202.04 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 15 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 13.17 | CX Basic pKa: 4.92 | CX LogP: 1.61 | CX LogD: 1.61 |
Aromatic Rings: 4 | Heavy Atoms: 46 | QED Weighted: 0.11 | Np Likeness Score: 0.40 |
1. Serpi M, Ferrari V, McGuigan C, Ghazaly E, Pepper C.. (2022) Synthesis and Characterization of NUC-7738, an Aryloxy Phosphoramidate of 3'-Deoxyadenosine, as a Potential Anticancer Agent., 65 (23.0): [PMID:36417756] [10.1021/acs.jmedchem.2c01348] |
Source(1):